(19)

(11)

EP 2 142 927 A1

(12)

(43) Date of publication: 13.01.2010 Bulletin 2010/02 (21) Application number: 02749582.9 (22) Date of filing: 13.06.2002

(51) International Patent Classification (IPC):  G01N 33/543(2006.01) G01N 33/544(2006.01) A61K 47/48(2006.01) C12Q 1/00(2006.01) A61K 49/00(2006.01) G01N 33/542(2006.01) G01N 33/533(2006.01) C09K 19/00(2006.01) (86) International application number: PCT/US2002/018657 (87) International publication number: WO 2003/106589 (24.12.2003 Gazette 2003/52)

(84) Designated Contracting States: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR Designated Extension States: AL LT LV MK RO SI (71) Applicant: Lyotropic Therapeutics, Inc. Ashland, VA 23005 (US)	(72) Inventor: ANDERSON, David, M. Colonial Heights, VA 23834 (US) (74) Representative: Kröncke, Rolf  Gramm, Lins & Partner GbR Freundallee 13a 30173 Hannover 30173 Hannover (DE) (56) References cited: :